AdaptHealth (AHCO) Gross Margin (2019 - 2026)
AdaptHealth's (AHCO) quarterly Gross Margin came in at 13.6% in Q1 2026, down 188.0% year-on-year from 15.46% in Q1 2025, and down 33.14% quarter-over-quarter from 20.34% in Q4 2025.
AdaptHealth (AHCO) Gross Margin (2019 - 2026) Analysis & Trends
AdaptHealth's Gross Margin history runs 8 years deep, the most recent figure standing at 13.6% for Q1 2026.
- On a quarterly basis, Gross Margin fell 188.0% year-over-year to 13.6% in Q1 2026; TTM through Mar 2026 was 18.26%, a 158.0% decrease from a year earlier, with the FY2025 full-year figure at 18.77%, down 211.0% from the prior year.
- Gross Margin eased to 13.6% in Q1 2026 per AHCO's latest filing, from 20.34% in the prior quarter.
- Across five years, Gross Margin topped out at 35.47% in Q4 2023 and bottomed at 11.98% in Q1 2023.
- The 5-year median for Gross Margin is 19.32% (2025), against an average of 19.15%.
- Across the five-year window, Gross Margin surged 1549 bps in 2022 and sank 1303 bps in 2024, its largest moves.
- Year by year, Gross Margin stood at 31.23% in 2022, then advanced by 14 bps to 35.47% in 2023, then plunged by 37 bps to 22.44% in 2024, then decreased by 9 bps to 20.34% in 2025, then tumbled by 33 bps to 13.6% in 2026.
- Per Business Quant, the three latest AHCO Gross Margin figures stand at 13.6% (Q1 2026), 20.34% (Q4 2025), and 19.74% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AdaptHealth | 1.42 Bn | 1.38 Bn | 111.50 Mn | 13.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.60% |
| Dec 31, 2025 | 20.34% |
| Sep 30, 2025 | 19.74% |
| Jun 30, 2025 | 19.32% |
| Mar 31, 2025 | 15.48% |
| Dec 31, 2024 | 22.44% |
| Sep 30, 2024 | 20.11% |
| Jun 30, 2024 | 21.01% |
| Mar 31, 2024 | 19.87% |
| Dec 31, 2023 | 35.47% |
| Sep 30, 2023 | 13.75% |
| Jun 30, 2023 | 15.11% |
| Mar 31, 2023 | 11.98% |
| Dec 31, 2022 | 31.23% |
| Sep 30, 2022 | 14.51% |
| Jun 30, 2022 | 16.16% |
| Mar 31, 2022 | 15.45% |
| Dec 31, 2021 | 15.74% |
| Sep 30, 2021 | 18.89% |
| Jun 30, 2021 | 20.47% |